2010 was a challenge from the start. What could be expected after the – for the chemical industry -depressive 2009? With an ambitious sales budget Axcentive was tremendously motivated to do better than the market. This was supported by significant investments in marketing, sales, promotion, CRM and other public relations. Making Axcentive more visible was (and is) the credo.
The result was that we are now back on the growth curve and surpassing already 2007 turnover. The raw material cost remains volatile and this means it is a dynamic market with prices fluctuating. Under these conditions our focused approach to Sulfonamides and related products often enables us to prepare the best deal for our customers and whenever possible ‘peak shave’ prices. This allows our customers to work with a more stable price base.
2011 should be another growth year with the introduction of our new Ketjenflex® 12 and more growth for amongst other Ketjenflex CP expected.